{
  "ptid_time": "041_S_1423_2008-02-05",
  "img_path": "/data/qiuhui/data/adni/images/041_S_1423/2008-02-05/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 46,343 mm³, 54.3% above the reference mean. With a Z-score of 1.29 (90.2th percentile), this represents mild enlargement; hippocampal volume measures 7,100 mm³, 11.5% below the reference mean. With a Z-score of -1.15 (12.4th percentile), this represents mild atrophy; whole brain volume measures 1,022,880 mm³, 9.8% below the reference mean. With a Z-score of -1.39 (8.2th percentile), this represents mild atrophy; entorhinal cortex volume measures 3,130 mm³, 26.6% below the reference mean. With a Z-score of -1.84 (3.3th percentile), this represents moderate atrophy; fusiform gyrus volume measures 17,506 mm³, 12.1% below the reference mean. With a Z-score of -1.00 (15.8th percentile), this represents mild atrophy; middle temporal gyrus volume measures 18,535 mm³, 17.3% below the reference mean. With a Z-score of -1.42 (7.7th percentile), this represents mild atrophy. ",
  "text_data": "Age is 69.9 years. Gender is Male. Education: 19 years. MMSE: 28.0. APOEε4 alleles: 1.0. ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows mild to moderate atrophy in key Alzheimer's-related regions (hippocampus, entorhinal cortex, middle temporal gyrus), alongside ventricular enlargement, suggesting neurodegeneration. The MMSE score of 28 is within normal limits, but structural changes raise concern for early pathology.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (Clinical-MMSE discrepancy with imaging findings; APOE4 carrier status supports risk but not definitive progression.)  \n\n*Note: Follow-up cognitive testing (e.g., MoCA) and biomarker analysis (CSF Aβ/tau or PET) would strengthen confidence.*",
  "timestamp": "2025-07-26T07:07:38.694779"
}